​

ProQR Therapeutics (PRQR) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

ProQR Therapeutics Revenue Highlights

Latest Revenue (Y)

$6.38M

Latest Revenue (Q)

$4.48M

Main Segment (Y)

Up-front payments

ProQR Therapeutics Revenue by Period

ProQR Therapeutics Revenue by Year

DateRevenueChange
2023-12-31$6.38M58.05%
2022-12-31$4.04M198.15%
2021-12-31$1.35M100.00%
2020-12-31--100.00%
2019-12-31$1.93M-60.88%
2018-12-31$4.94M-423.15%
2017-12-31$-1.53M-167.00%
2016-12-31$2.28M-75.74%
2015-12-31$9.41M2905.43%
2014-12-31$313.00K100.00%
2013-12-31--

ProQR Therapeutics generated $6.38M in revenue during NA 2023, up 58.05% compared to the previous quarter, and up 129.13% compared to the same period a year ago.

ProQR Therapeutics Revenue by Quarter

DateRevenueChange
2024-03-31$4.48M39.89%
2023-12-31$3.20M133.56%
2023-09-30$1.37M13.69%
2023-06-30$1.21M83.97%
2023-03-31$655.00K-20.32%
2022-12-31$822.00K-14.02%
2022-09-30$956.00K-6.73%
2022-06-30$1.02M-16.94%
2022-03-31$1.23M416.32%
2021-12-31$239.00K-72.59%
2021-09-30$872.00K258.85%
2021-06-30$243.00K100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--100.00%
2019-12-31$1.93M100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31--100.00%
2018-12-31$4.94M100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--100.00%
2017-12-31$-1.53M100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31--100.00%
2016-12-31$2.28M100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31--100.00%
2014-12-31$309.00K100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30--

ProQR Therapeutics generated $4.48M in revenue during Q1 2024, up 39.89% compared to the previous quarter, and up 544.55% compared to the same period a year ago.

ProQR Therapeutics Revenue Breakdown

ProQR Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21
Milestone payments$5.10M---
Up-front payments$15.58M$6.00M$191.00K$252.00K
R&D services--$118.00K$282.00K
Premiums on share issue--$48.00K$168.00K

ProQR Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 24: Up-front payments (75.36%), and Milestone payments (24.64%).

ProQR Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ALNYAlnylam Pharmaceuticals$2.25B$420.15M
APLSApellis Pharmaceuticals$709.95M$176.57M
BPMCBlueprint Medicines$508.82M$128.18M
CTMXCytomX Therapeutics$138.10M$33.43M
DAWNDay One Biopharmaceuticals$131.16M$20.07M
WVEWave Life Sciences$108.30M$19.69M
SPROSpero Therapeutics$47.98M$13.47M
NUVBNuvation Bio$7.87M$727.00K
PRQRProQR Therapeutics$6.38M$4.48M
ARWRArrowhead Pharmaceuticals$3.55M$2.50M
ACHLAchilles Therapeutics--
ANNXAnnexon--
NXTCNextCure--
TILInstil Bio--
TERNTerns Pharmaceuticals--
ASMBAssembly Biosciences-$6.84M

PRQR Revenue FAQ

What is ProQR Therapeutics’s yearly revenue?

ProQR Therapeutics's yearly revenue for 2023 was $6.38M, representing an increase of 58.05% compared to 2022. The company's yearly revenue for 2022 was $4.04M, representing an increase of 198.15% compared to 2021. PRQR's yearly revenue for 2021 was $1.35M, representing an increase of 100.00% compared to 2020.

What is ProQR Therapeutics’s quarterly revenue?

ProQR Therapeutics's quarterly revenue for Q1 2024 was $4.48M, a 39.89% increase from the previous quarter (Q4 2023), and a 583.39% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $3.2M, a 133.56% increase from the previous quarter (Q3 2023), and a 289.26% increase year-over-year (Q4 2022). PRQR's quarterly revenue for Q3 2023 was $1.37M, a 13.69% increase from the previous quarter (Q2 2023), and a 43.31% increase year-over-year (Q3 2022).

What is ProQR Therapeutics’s revenue growth rate?

ProQR Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 371.23%, and for the last 5 years (2019-2023) was 230.08%.

What are ProQR Therapeutics’s revenue streams?

ProQR Therapeutics's revenue streams in c 24 are Milestone payments, and Up-front payments. Milestone payments generated $5.1M in revenue, accounting 24.64% of the company's total revenue Up-front payments generated $15.58M in revenue, accounting 75.36% of the company's total revenue, up 159.91% year-over-year.

What is ProQR Therapeutics’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of ProQR Therapeutics was Up-front payments. This segment made a revenue of $15.58M, representing 75.36% of the company's total revenue.